Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

State-of-the-art gene therapy in epilepsy

7 Feb 2025

Abstract excerpt

PURPOSE OF REVIEW: Gene therapy in epilepsy has undergone a rapid expansion in recent years. This has largely been driven by both advances in our understanding of epilepsy genetics and mechanisms, and also significant advances in gene therapy tools, in particular safe and effective viral vectors. Epilepsy remains an ideal target disease for gene therapy and this review highlights recent developments in this area....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epilepsy research and treatment
Share to Neurogenetic and Muscular Disorders Research
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39917784
DOI: 10.1097/wco.0000000000001349

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

State-of-the-art gene therapy in epilepsyPMID 39917784Read ↗

Targeted Gene and Genome Editing Strategies for Epilepsy: Advances and Translational ChallengesSemantic proximity Read ↗

Uncovering targets and molecular pathways for personalizing treatment in epilepsy.Semantic proximity Read ↗

Antisense oligonucleotides as a precision therapy for developmental and epileptic encephalopathiesSemantic proximity Read ↗

Gene Therapy Repairs for the Epileptic Brain: Potential for Treatment and Future Directions.Semantic proximity Read ↗

Antisense oligonucleotide therapy for <i>KCNT1</i> encephalopathySemantic proximity Read ↗

Antisense oligonucleotide therapy for SCN2A gain-of-function epilepsySemantic proximity Read ↗

Antisense oligonucleotide therapy for KCNT1 encephalopathySemantic proximity Read ↗

Targeting epilepsy genes.Semantic proximity Read ↗

Antisense oligonucleotide therapy reduces seizures and extends life span in an SCN2A gain-of-function epilepsy model.Semantic proximity Read ↗

Epilepsy gene therapy using non-integrating lentiviral delivery of an engineered potassium channel geneSemantic proximity Read ↗

SLC13A5 Deficiency Disorder: From Genetics to Gene Therapy.Semantic proximity Read ↗

Dynorphin‐based “release on demand” gene therapy for drug‐resistant temporal lobe epilepsySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.